Literature DB >> 8612674

TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin.

J A Nemeth1, A Rafe, M Steiner, C L Goolsby.   

Abstract

In addition to proteinase-inhibitory activities, growth-stimulatory activities have been described for all three known members of the tissue inhibitors of the metalloproteinase (TIMP) family, TIMP-1, TIMP-2, and ChIMP-3, believed to be the chicken homologue of TIMP-3. However, the mechanism by which the TIMPs stimulate cell growth is unclear. In this report we have demonstrated that rTIMP-2 was growth-stimulatory for human foreskin fibroblasts (HSF4, HSF43, HS68), lung adenocarcinoma cells (A549), human melanoma cells (WM115), and the Burkitt's lymphoma cell line RAMOS, and this stimulatory response was concentration-dependent, with the greatest stimulation occurring a 10-30 pM rTIMP-2 in [3H]thymidine incorporation assays and at 20-100 pM in cell growth assays. Normal human colon (18Co) and lung (37Lu) fibroblasts showed no response to rTIMP-2. [3H]Thymidine incorporation was inhibited by rTIMP-2 treatment in the nonadherent cell line HL60. These studies also demonstrated that for the cell types tested, TIMP-2 alone was insufficient for a growth stimulatory response requiring, at a minimum, the presence of insulin. In the absence of any "co-factor(s)," such as insulin, TIMP-2 treatment was inhibitory.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612674     DOI: 10.1006/excr.1996.0117

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.

Authors:  J Barasch; J Yang; J Qiao; P Tempst; H Erdjument-Bromage; W Leung; J A Oliver
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

Review 4.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

5.  Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression.

Authors:  S T Khuth; H Akaoka; A Pagenstecher; O Verlaeten; M F Belin; P Giraudon; A Bernard
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; S D Shapiro; I L Campbell
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

7.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Rian Disci; Sidika Kurul; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 8.  Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

Authors:  William G Stetler-Stevenson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

9.  Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats.

Authors:  Judit Marsillach; Natàlia Ferré; Jordi Camps; Anna Rull; Raul Beltran; Jorge Joven
Journal:  Mol Cell Biochem       Date:  2007-10-16       Impact factor: 3.396

10.  Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells.

Authors:  Jun Sun; William G Stetler-Stevenson
Journal:  J Mol Signal       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.